Challenger Limited (CFIGF)
| Market Cap | 4.41B +38.6% |
| Revenue (ttm) | 1.87B -6.8% |
| Net Income | 306.03M +214.7% |
| EPS | 0.43 +211.5% |
| Shares Out | n/a |
| PE Ratio | 14.41 |
| Forward PE | 12.54 |
| Dividend | 0.21 (3.70%) |
| Ex-Dividend Date | Feb 24, 2026 |
| Volume | 3,791 |
| Average Volume | 12,791 |
| Open | 5.60 |
| Previous Close | 5.60 |
| Day's Range | 5.60 - 5.60 |
| 52-Week Range | 4.53 - 5.79 |
| Beta | 0.61 |
| RSI | 66.90 |
| Earnings Date | Aug 18, 2026 |
About Challenger
Challenger Limited is a publicly owned investment manager. The company also provides retirement services to its clients. It manages equity mutual funds. The firm invests into the public equity markets across the world. Challenger Limited was founded in 1985 and is based in Australia, Asia and United Kingdom. [Read more]
Financial Performance
In fiscal year 2025, Challenger's revenue was 3.09 billion, an increase of 10.78% compared to the previous year's 2.79 billion. Earnings were 192.30 million, an increase of 48.04%.
Financial numbers in AUD Financial StatementsNews
Challenger Earnings Call Transcript: H1 2026
H1 2026 saw earnings and returns above target, record annuity sales, and strong capital management, with an increased dividend and a planned AUD 150 million buyback. Strategic partnerships, technology upgrades, and offshore expansion position the business for continued growth.
Challenger Transcript: Investor Update
APRA's proposed capital standards for longevity products will materially reduce capital intensity, enhance resilience, and support growth and innovation in retirement solutions. The reforms are expected to lower earnings volatility, improve capital flexibility, and spur industry competition.
Challenger Transcript: AGM 2025
Celebrating 40 years, the meeting highlighted strong financial results, board renewal, and a focus on digital transformation and sustainability. Shareholders approved all resolutions, and optimism was expressed for future growth amid regulatory reforms and evolving market conditions.
Challenger Earnings Call Transcript: H2 2025
FY 2025 delivered 9% growth in earnings and EPS, with ROE above target and a record dividend increase. Strategic partnerships, product innovation, and digital transformation position the business for sustainable growth, while APRA capital reforms are expected to further enhance flexibility and returns.
Challenger Earnings Call Transcript: H1 2025
Double-digit earnings growth and ROE above target were achieved, driven by record annuity sales, cost optimization, and technology investment. Capital strength remains high, and FY25 guidance is reaffirmed, with continued focus on long-term growth.
Challenger Transcript: AGM 2024
The meeting reviewed strong financial results, with profit and assets under management both rising significantly. Board composition was refreshed, dividends increased, and progress made on ESG and diversity. Strategic investments in technology and partnerships were highlighted, with all director elections and resolutions supported.
Challenger Earnings Call Transcript: H2 2024
Delivered strong FY 2024 results with 17% growth in normalized pre-tax profit and 21% AUM increase, driven by longer-duration Life sales and cost discipline. ROE rose to 15.6%, and guidance for FY 2025 targets further profit and efficiency gains.
Challenger Earnings Call Transcript: H1 2024
Challenger Transcript: Status Update
Challenger Transcript: AGM 2023
Challenger Ltd. upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Julian Braganza upgraded Challenger Ltd. to Buy from Neutral with a A$6.89 price target. The company’s return on equity should continue to improve into fiscal 2024 primarily
Challenger Earnings Call Transcript: H2 2023
Challenger Transcript: Investor Day 2023
Challenger Ltd. upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst James Cordukes upgraded Challenger Ltd. to Outperform from Neutral with a price target of A$7.10, down from A$7.70. The analyst says value has emerged in the shares